BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30431059)

  • 1. Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease.
    Gao JX; Li Y; Wang SN; Chen XC; Lin LL; Zhang H
    Int J Mol Med; 2019 Jan; 43(1):209-220. PubMed ID: 30431059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
    Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
    Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Yao Y; Zhao Z; Zhang F; Miao N; Wang N; Xu X; Yang C
    Brain Behav; 2023 Mar; 13(3):e2921. PubMed ID: 36795044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-183 inhibits autophagy and apoptosis in gastric cancer cells by targeting ultraviolet radiation resistance-associated gene.
    Yuan Y; Zhang Y; Han L; Sun S; Shu Y
    Int J Mol Med; 2018 Dec; 42(6):3562-3570. PubMed ID: 30221685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
    Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
    J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway.
    Zhai H; Kang Z; Zhang H; Ma J; Chen G
    J Integr Neurosci; 2019 Dec; 18(4):423-429. PubMed ID: 31912701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
    Liu YY; Zhang YN; Yang QS
    J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model.
    Xu BB; Liu CQ; Gao X; Zhang WQ; Wang SW; Cao YL
    J Asian Nat Prod Res; 2005 Jun; 7(3):215-24. PubMed ID: 15621629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of electroacupuncture on oxidative stress and cell apoptosis induced by ferroptosis in mice with Parkinson's disease.
    Ma X; Liu F; Wang Q; Wang Y; Liu ZB
    Zhen Ci Yan Jiu; 2023 Dec; 48(12):1242-1248. PubMed ID: 38146247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons.
    Chen XC; Chen Y; Zhu YG; Fang F; Chen LM
    Acta Pharmacol Sin; 2002 Sep; 23(9):829-34. PubMed ID: 12230953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of adrenomedullin protects mesenchymal stem cells against hypoxia and serum deprivation‑induced apoptosis via the Akt/GSK3β and Bcl‑2 signaling pathways.
    Si H; Zhang Y; Song Y; Li L
    Int J Mol Med; 2018 Jun; 41(6):3342-3352. PubMed ID: 29512737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-483-3p regulates acute myocardial infarction by transcriptionally repressing insulin growth factor 1 expression.
    Sun H; Cai J; Xu L; Liu J; Chen M; Zheng M; Wang L; Yang X
    Mol Med Rep; 2018 Mar; 17(3):4785-4790. PubMed ID: 29363719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
    Yalçınkaya N; Haytural H; Bilgiç B; Özdemir Ö; Hanağası H; Küçükali Cİ; Özbek Z; Akcan U; İdrisoğlu HA; Gürvit H; Tüzün E
    Neurosci Lett; 2016 Feb; 615():72-7. PubMed ID: 26806867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease.
    Zhao XH; Wang YB; Yang J; Liu HQ; Wang LL
    J Cell Biochem; 2019 Sep; 120(9):14995-15006. PubMed ID: 31135066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Viral myocarditis serum exosome-derived miR-320 promotes the apoptosis of mouse cardiomyocytes by inhibiting AKT/mTOR pathway and targeting phosphatidylinositol 3-kinase regulatory subunit 1 (Pik3r1)].
    Zhang X; Li X; Zhu L; Yin G; Zhang Y; Lyu K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):516-525. PubMed ID: 37340920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
    Dong Y; Han LL; Xu ZX
    Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puerarin prevents inflammation and apoptosis in the neurocytes of a murine Parkinson's disease model.
    Jiang M; Yun Q; Niu G; Gao Y; Shi F; Yu S
    Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑155 contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR signaling pathway.
    Duan W; Chen Y; Wang XR
    Int J Mol Med; 2018 Sep; 42(3):1577-1584. PubMed ID: 29901097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
    Malagelada C; Ryu EJ; Biswas SC; Jackson-Lewis V; Greene LA
    J Neurosci; 2006 Sep; 26(39):9996-10005. PubMed ID: 17005863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.